ARIAD Pharma (ARIA) Tops Q3 EPS by 7c

November 7, 2016 7:36 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

ARIAD Pharma (NASDAQ: ARIA) reported Q3 EPS of ($0.12), $0.07 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $34.3 million versus the consensus estimate of $42.93 million.

ARIAD Pharma reaffirmed FY2016 guidance.

For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment